Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03074643 · ClinicalTrials.gov registry record · NA
Utilizing Protein During Weight Loss to Impact Physical Function
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 187
- Enrollment target
NCT03074643: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT03074643 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 187 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03074643, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 187 participants
- Enrollment target
Study Summary
This study will evaluate the effects of diet composition (i.e., amount of protein and carbohydrate) during a 6-month weight loss intervention and 12-months of follow-up on physical function, muscle mass, and weight loss maintenance in obese older adults. Participants will receive either a protein or carbohydrate supplement along with a behavioral weight loss intervention.
Primary Outcome
To determine the effects of a higher protein / lower CHO diet vs. lower protein / higher CHO diet during a 6-month weight loss intervention and 12 months of follow-up on change in lower extremity physical function assessed by the expanded Short Physical Performance Battery score over 18 months. The expanded Short Physical Performance Battery score ranges from 0 to 4 with higher scores indicating better lower extremity physical function
Interventions
- BEHAVIORAL Weight loss intervention months 0-6
- BEHAVIORAL Exercise intervention months 0-6
- DIETARY_SUPPLEMENT Carbohydrate supplement for months 0-6
- DIETARY_SUPPLEMENT Protein supplement for months 0-6
- DIETARY_SUPPLEMENT Protein supplement for follow-up months 7-18
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2022-04-28 |
| Phase | NA |
What the finished NCT03074643 record still lists
NCT03074643 is an interventional study that assigns participants to a tested intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 5 interventions - of which Weight loss intervention months 0-6 is the first listed.
NCT03074643 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03074643 about?
NCT03074643 is a clinical study titled "Utilizing Protein During Weight Loss to Impact Physical Function". This study will evaluate the effects of diet composition (i.e., amount of protein and carbohydrate) during a 6-month weight loss intervention and 12-months of follow-up on physical function, muscle mass, and weight loss maintenance in obese older adults. Participants will receive either a protein or...
What is the current status of trial NCT03074643?
This trial is currently completed. It is a NA study. The enrollment target is 187 participants. The study started on 2017-05-03. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT03074643?
The interventions under investigation include: Weight loss intervention months 0-6 (BEHAVIORAL), Exercise intervention months 0-6 (BEHAVIORAL), Carbohydrate supplement for months 0-6 (DIETARY_SUPPLEMENT), Protein supplement for months 0-6 (DIETARY_SUPPLEMENT), Protein supplement for follow-up months 7-18 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03074643?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03074643's enrollment target sits among peer trials
187 579th of 2000 higher than 1,422 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI